Effect of Monoclonal Antibody to Human Zone Pellucida 3 on Bone Morphogenetic Protein 15 Expression and Number of Preantral and Antral Follicles in Ovary of Mice
Journal Title: Turkish Journal of Immunology - Year 2017, Vol 5, Issue 3
Abstract
Introduction: Immunocontraception of zone pellucide (ZP3) is known causing disturbance of gap junction which inhibits transport growth factor such as bone morphogenetic protein (BMP-15). Decreased BMP-15 generates disturbance of proliferation and differentiation of follicle, granulosa, and techa cells. Anti-Human ZP3 monoclonal antibody with high specificity is being developed to prevent such effects. This study aimed to evaluate the effect of Mab-hZP3 on the expression of BMP-15 and number of preantral and antral follicles in the ovary of mice. Materials and Methods: This was true experiment post-test only control group design. Subjects involved were 48 mice (Mus musculus) that were divided into control (adjuvant) and treatment group (Mab-hZP3 with dose of 20 µg, 40 µg, and 60 µg). In each group, a fraction of mice were killed at day 10, 15 and 20. Measurement of BMP-15 was performed with immunohistochemical, assessment, and a number of preantral and antral follicles was measured with hematoxylin and eosin. Results: Overall, results showed that there was no significant difference in the effects of Mab-hZP3 in a dose range of 20–60 µg on the expression of BMP-15 and number of preantral and antral follicles. A similar finding was also observed in the period of 10–20 days. Such results are suggested to be associated with the specificity of the monoclonal antibody. Conclusions: Anti-Human ZP3 monoclonal antibody has no effect on decreasing expression of BMP-15 and number of preantral and antral follicles. It is considered as effective and safe immunocontraception. Keywords: Antral follicle, BMP-15, monoclonal antibody, preantral follicle
Authors and Affiliations
Reny Retnaningsih, Endang Sri Wahyuni, Kusnarman Keman
Keywords
Related Articles
- EP ID EP449948
- DOI 10.25002/tji.2017.632
- Views 112
- Downloads 0
The Effect of Viral Infections and Allergic Inflammation in Asthmatic Patients on Immunotherapy
Introduction: The prevalence of allergic asthma are increasing, and the clinical outcome and risk factors of immunotherapy in the treatment of allergy have not been well established. Especially, the impact of viral infec...
Interleukin-2 Immunotherapy for Advanced Cancer
Interleukin-2 (IL-2) was the first approved immunotherapy to show efficacy in advanced cancer. 13–20% of patients with metastatic renal cell carcinoma and metastatic melanoma receiving high-dose IL-2 treatment showed obj...
The Association Between Vitamin D Levels and Infections in Patients with Primary Immunodeficiency
ntroduction: Vitamin D is a hormone responsible in the regulation of immune response. This study was designed to assess the relationship of vitamin D deficiency on the development of infections in patients with primary i...
Prevalence of HLA-DQ*02 and HLA-DQ*08 in Patients with Celiac Disease in Eastern Anatolia and the Diagnostic Role of HLA-DQ*02 and HLA-DQ*08 Genotyping
Introducton: Celiac disease (CD) is diagnosed with serological tests and small bowel biopsy. There is a strong link between CD and human leukocyte antigens (HLA). In this study, we aimed to determine the role of HLA alle...
The Relationship Between Serum Vitamin D (25(OH)D3), C-Peptide, and Interleukin-2 Level in Children with Type 1 Diabetes Mellitus
Introduction: Vitamin D is very important for Type 1 diabetes mellitus (T1 DM) pathogenesis, and plays major role in the regulation of pancreatic beta cells. However, serum vitamin D (25(OH)D3) level related to inflammat...